Title : Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants.

Pub. Date : 2006 Apr

PMID : 16612767






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Indeed, imatinib mesylate has become first-line therapy for patients in whom the FIP1L1-PDGFRalpha fusion gene is detected, whereas corticosteroids remain the mainstay for management of patients in whom hypereosinophilia is secondary to the overproduction of interleukin 5 by abnormal T-cells. Imatinib Mesylate factor interacting with PAPOLA and CPSF1 Homo sapiens